The immune checkpoint inhibitor market is a rapidly growing industry that is transforming cancer treatment. Immune checkpoint inhibitors are a type of immunotherapy that work by blocking certain proteins on cancer cells or immune cells, which allows the immune system to recognize and attack cancer cells. These drugs have shown remarkable results in treating various …
Tag Archives: Immune Checkpoint Inhibitors Market
Immune Checkpoint Inhibitors Market Size Worth USD 140.89 billion by 2030 | CAGR of 16.8%
According to the report published by Allied Market Research, The global Immune Checkpoint Inhibitors Market Size stood at USD 29.80 billion in 2020 and is projected to reach USD 140.89 billion by 2030, exhibiting a CAGR of 16.8% from 2021 to 2030. Rise in incidences of cancer across the world, surge in global geriatric population, …
Immune Checkpoint Inhibitors Market by Type (PD-1 Inhibitors, PD-L1 Inhibitors and CTLA-4 Inhibitor) Forecast, 2030
According to a new report published by Allied Market Research, titled, “Immune Checkpoint Inhibitors Market: Global Opportunity Analysis and Industry Forecast, 2021-2030” The global immune checkpoint inhibitors market was valued at $29,803.71 million in 2020, and is projected to reach $1,40,890.10 million by 2030, registering a CAGR of 16.8% from 2021 to 2030. Checkpoint inhibitor …